Alan D. Edgar

1.1k total citations
17 papers, 939 citations indexed

About

Alan D. Edgar is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Alan D. Edgar has authored 17 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Alan D. Edgar's work include Peroxisome Proliferator-Activated Receptors (8 papers), Metabolism, Diabetes, and Cancer (4 papers) and Mitochondrial Function and Pathology (3 papers). Alan D. Edgar is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (8 papers), Metabolism, Diabetes, and Cancer (4 papers) and Mitochondrial Function and Pathology (3 papers). Alan D. Edgar collaborates with scholars based in France, United States and Brazil. Alan D. Edgar's co-authors include Christiane Legendre, Thierry Pineau, Philippe Costet, P. Galtier, Jean Moré, Joanna B. Strosznajder, Lloyd A. Horrocks, Evelyne Chaput, Régis Saladin and L. Freysz and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Alan D. Edgar

16 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan D. Edgar France 13 618 319 197 145 106 17 939
Nathan D. Roe United States 14 629 1.0× 383 1.2× 197 1.0× 98 0.7× 69 0.7× 18 1.2k
Miyuki Yano Japan 12 772 1.2× 266 0.8× 237 1.2× 279 1.9× 151 1.4× 12 1.3k
Catherine A. Cullinan United States 8 713 1.2× 357 1.1× 155 0.8× 92 0.6× 109 1.0× 10 924
Chhabi Biswas United States 11 942 1.5× 455 1.4× 119 0.6× 142 1.0× 173 1.6× 13 1.2k
Ming-Hui Zou United States 11 423 0.7× 357 1.1× 178 0.9× 227 1.6× 173 1.6× 14 1.1k
JC Fruchart France 6 580 0.9× 165 0.5× 144 0.7× 100 0.7× 75 0.7× 9 896
Muriel Troly France 7 487 0.8× 509 1.6× 133 0.7× 150 1.0× 116 1.1× 9 1.1k
Lele Ji China 18 784 1.3× 198 0.6× 185 0.9× 95 0.7× 106 1.0× 31 1.3k
P. H. M. Willemsen Netherlands 19 907 1.5× 431 1.4× 63 0.3× 119 0.8× 83 0.8× 25 1.3k
William S. Cook United States 8 641 1.0× 426 1.3× 402 2.0× 143 1.0× 119 1.1× 16 1.1k

Countries citing papers authored by Alan D. Edgar

Since Specialization
Citations

This map shows the geographic impact of Alan D. Edgar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan D. Edgar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan D. Edgar more than expected).

Fields of papers citing papers by Alan D. Edgar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan D. Edgar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan D. Edgar. The network helps show where Alan D. Edgar may publish in the future.

Co-authorship network of co-authors of Alan D. Edgar

This figure shows the co-authorship network connecting the top 25 collaborators of Alan D. Edgar. A scholar is included among the top collaborators of Alan D. Edgar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan D. Edgar. Alan D. Edgar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
3.
Deehan, Renée, Natalie L. Catlett, Guido Steiner, et al.. (2012). Comparative Transcriptional Network Modeling of Three PPAR-α/γ Co-Agonists Reveals Distinct Metabolic Gene Signatures in Primary Human Hepatocytes. PLoS ONE. 7(4). e35012–e35012. 18 indexed citations
4.
Edgar, Alan D., Robert M. Levin, Christos E. Constantinou, & Louis Denis. (2007). A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS. Neurourology and Urodynamics. 26(4). 458–463. 20 indexed citations
5.
Tomkiewicz, Céline, Françoise Muzeau, Alan D. Edgar, Robert Barouki, & Μartine Aggerbeck. (2003). Opposite regulation of the rat and human cytosolic aspartate aminotransferase genes by fibrates. Biochemical Pharmacology. 67(2). 213–225. 13 indexed citations
6.
Legendre, Christiane, E Caussé, Evelyne Chaput, et al.. (2002). Fenofibrate induces a selective increase of protein-bound homocysteine in rodents: a PPARα-mediated effect. Biochemical and Biophysical Research Communications. 295(5). 1052–1056. 19 indexed citations
7.
Perrey, Stéphane, Christiane Legendre, Akihiro Matsuura, et al.. (2001). Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis. Atherosclerosis. 155(2). 359–370. 40 indexed citations
8.
Chaput, Evelyne, et al.. (2000). Fenofibrate and Rosiglitazone Lower Serum Triglycerides with Opposing Effects on Body Weight. Biochemical and Biophysical Research Communications. 271(2). 445–450. 176 indexed citations
9.
Chaput, Evelyne, et al.. (1999). Fenofibrate protects lipoproteins from lipid peroxidation: Synergistic interaction with α‐tocopherol. Lipids. 34(5). 497–502. 17 indexed citations
10.
Edgar, Alan D., Céline Tomkiewicz, Philippe Costet, et al.. (1998). Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway. Toxicology Letters. 98(1-2). 13–23. 58 indexed citations
11.
Costet, Philippe, Christiane Legendre, Jean Moré, et al.. (1998). Peroxisome Proliferator-activated Receptor α-Isoform Deficiency Leads to Progressive Dyslipidemia with Sexually Dimorphic Obesity and Steatosis. Journal of Biological Chemistry. 273(45). 29577–29585. 347 indexed citations
12.
McPherson, Ruth, G. Agnani, Paulina Lau, et al.. (1996). Role of Lp A-I and Lp A-I/A-II in Cholesteryl Ester Transfer Protein–Mediated Neutral Lipid Transfer. Arteriosclerosis Thrombosis and Vascular Biology. 16(11). 1340–1346. 22 indexed citations
13.
Chagnon, Marie‐Christine, et al.. (1995). Fenofibrate: Metabolism and Species Differences for Peroxisome Proliferation in Cultured Hepatocytes. Toxicological Sciences. 26(1). 63–74. 2 indexed citations
14.
Edgar, Alan D. & S. E. Pfeiffer. (1985). Extracts from Neuron-Enriched Cultures of Chick Telencephalon Stimulate the Proliferation of Rat Oligodendrocytes. Developmental Neuroscience. 7(4). 206–215. 21 indexed citations
15.
Edgar, Alan D., L. Freysz, L. A. Horrocks, & P. Mandel. (1984). Specific stimulation of phospholipase activities with phosphatidylethanolamine in transformed cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 796(3). 238–242. 2 indexed citations
16.
Edgar, Alan D., Joanna B. Strosznajder, & Lloyd A. Horrocks. (1982). Activation of Ethanolamine Phospholipase A2 in Brain During Ischemia. Journal of Neurochemistry. 39(4). 1111–1116. 156 indexed citations
17.
Edgar, Alan D. & L. Freysz. (1982). Phospholipase activities of rat brain cytosol occurrence of phospholipase c activity with phosphatidylcholine. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 711(2). 224–228. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026